#Biotech

Circular Genomics Secures $15 Million Series A for Alzheimer's Blood Test

AlphaFold Protein Prediction Reshapes APAC Research

AI gene editing platform aims to make CRISPR scalable

BioCLIP 2: A Biology Foundation Model for Ecosystem Insights

Generative Antibody Design Cracks 'Undruggable' Targets

Onepot AI Secures $13 Million to Revolutionize Chemical Synthesis for Drug Discovery

The Genomic LLM is here to decode 98% of human DNA

Modulight Secures $12 Million Seed Round for Light-Based Brain Therapy

Gina Raimondo: U.S. needs to lead in AI, quantum and biotech in order to win and outcompete China

Primaa raises €7M to advance AI cancer diagnostics

\n Biotech company Primaa has raised €7 million to expand its AI cancer diagnostics software.

Lilly Blackwell Drug Discovery: A New Era

Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge

Tahoe-x1 single cell model scales AI for cancer drug discovery

Valthos AI Biodefense Secures $30M to Combat Programmable Biology

Revyve Secures €24M Series B for Egg-Replacing Yeast Proteins

\n Revyve , a Dutch FoodTech scale-up, has secured €24 million in Series B funding. ABN AMRO Sustainable Impact Fund and Invest-NL co-led the round.

Biotech's AI Infusion: A Tremendous Opportunity

Synthesize Bio Raises $10M Seed for Generative Genomics

Synthesize Bio raised $10M for generative genomics. Its GEM-1 model accelerates drug discovery.

Terra Oleo Secures $3.1M for Sustainable Oil Production

Virtual Cells: Unlocking Biology's Latent Speed with AI

Ridge Bio Secures $25M Seed for AI-Enabled Drug Design

GPT-5 Ignites Moderna's Second Computing Revolution

NRG Therapeutics Secures £50M Series B for ALS, Parkinson's Drugs

NRG Therapeutics secured £50 million in Series B funding, led by SV Health Investors’ Dementia Discovery Fund. This investment will advance mitochondrial-targeting treatments for neurodegenerative diseases. The company aims to transition its pipeline, including lead candidate NRG5051 for ALS and Parkinson's, into...

BoobyBiome Secures €2.8M Seed for Infant Health Solutions

Enveda Secures $150M Series D, Achieves Unicorn Status

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies

Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.

British EnsiliTech Secures €5.2M Seed for Cold-Chain Biopharma

EnsiliTech secured €5.2 million in Seed funding, led by Eos Advisory. This capital will advance its patented Ensilication technology, which stabilizes biopharmaceuticals at higher temperatures. The innovation aims to eliminate cold-chain reliance, revolutionizing global biopharma transport.

German Detechgene Secures €3.2M for Mobile Lab Diagnostics

German biotech Detechgene secured €3.2 million in its second Seed round, led by Neoteq ventures. The company develops 'PCR to Go', a mobile platform for fast, lab-accurate molecular diagnostics. This funding will commercialise its platform, advancing decentralized healthcare diagnostics.

AMD Ventures Backs Somite.ai with Strategic Investment to Accelerate Foundation Models for Cell Therapy

Oxford's SugaROx Secures €1.1M for Biostimulant Scale-Up

Oxford's SugaROx secured €1.1 million in a seed round extension. The Mosaic Company led this funding round, contributing £400k. This investment accelerates the development and production of its crop-enhancing biostimulants.

Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.

Tahoe Therapeutics Raises $30M for AI Human Cell Models

Tahoe Therapeutics secured $30 million in new funding. Amplify Partners led the round. This capital will fuel the creation of AI models of human cells to advance drug discovery.

Latvian Cellbox Labs Lands €3.3M for Organ-on-Chip Innovation

Latvian Cellbox Labs secured €3.3 million in non-dilutive funding. This capital, partly from the IPCEI “Tech4Cure” initiative, supports its organ-on-chip technology development. The investment aims to advance drug discovery and reduce reliance on animal testing.

SNIPR Biome Secures €35M Series B for CRISPR Therapies

SNIPR Biome, a Danish biotech, secured €35 million in Series B funding. New investors Cystic Fibrosis Foundation and SPRIN-D joined the round, alongside existing backers. This capital will advance its microbial CRISPR-medicine development, including therapies for cystic fibrosis and antimicrobial resistance.

SNIPR Biome Secures €35M Series B for CRISPR Therapies

Copenhagen-based SNIPR Biome , a Danish biotech scale-up, secured €35 million in Series B funding.

Chai Discovery Secures $70M for AI Drug Development

AI drug development startup Chai Discovery has raised $70 million in a Series A round led by Menlo Ventures. The new capital will be used to advance its AI platform and pursue previously inaccessible drug targets. As part of its expansion, former Pfizer Chief Scientific Officer Mikael Dolsten is joining the company'...

Lithuanian Psylink Secures €500k for Mental Health BioTech

Lithuanian Psylink Secures €500k for Mental Health BioTech

Vilnius-based Psylink secured over €500k in a pre-Seed funding round led by Coinvest Capital.

Biostate AI Expands Global Reach with Strategic Partnerships in US, China, and India

Plexision Secures $365K for AI Transplant Prediction

ASTRA Therapeutics Raises €8.3M for Precision Animal Parasiticides

NetZeroNitrogen Secures $6.6M Seed for Bio-Fertilizer

Provectus Algae Raises $12.6M for Algae Methane Reduction

PODCAST: I've Learned to Avoid Saying 'Never' Because Technology Proceeds in Ways that you Often Don’t Expect

ScienceMachine Secures €2.9M for BioTech AI Analysis

YC-Alum Argon AI Secures $5.5 Million Seed Funding to be Perplexity for Life Sciences

Antler Bio Secures $3.9 Million for Dairy Gene Expression Technology

Kyron.bio Raises €5.5M to Advance Glycan-Engineered Drug Design

Biostate AI Raises $12M Series A to Power GenAI for Molecular Diagnostics

<p>Accel leads investment to scale RNA sequencing platform that predicts disease and treatment response using generative AI.</p>

Startup Funding Rounds of December 9, 2024

<p>Dutch startup Citryll has secured €85 million in a Series B funding round, co-led by Johnson & Johnson Innovation, Forbion, and Novartis Venture Fund.</p><p>The funds will support the clinical development of CIT-013, a first-in-class antibody targeting Neutrophil Extracellular Traps (NETs), addressing severe inflammatory diseases.</p><p>This funding round also sees new board appointments from leading investors, enhancing Citryll's mission to provide innovative treatment options.</p>